White House Backs Bayer's Bid for Supreme Court Review in Roundup Case

Dow Jones12-02
 

By Billy Gray

 

Bayer said it welcomed the U.S. Solicitor General's support for a Supreme Court review of a case that could curtail longrunning litigation regarding its Roundup pesticide.

The German life-sciences company said the government's support would be significant as the Court weighs its petition, arguing that federal pesticide law preempts state-level failure-to-warn claims. This could limit tens of thousands of lawsuits alleging that the company's Roundup weed-killer causes cancer.

Solicitor General D. John Sauer in a brief said that "[the Environmental Protection Agency] has repeatedly determined that glyphosate is not likely to be carcinogenic in humans, and the agency has repeatedly approved Roundup labels that did not contain cancer warnings."

Bayer previously stated that it aims to significantly contain Roundup litigation by the end of 2026.

 

Write to Billy Gray at william.gray@wsj.com

 

(END) Dow Jones Newswires

December 02, 2025 02:27 ET (07:27 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment